SHMT1 acts as a tumor suppressor in HCC by suppressing NADPH oxidase 1, thereby reducing ROS levels and inhibiting epithelial-mesenchymal transition (Dou et al., 2019). The gene discussed is SHMT1; the disease is hepatocellular carcinoma.